外科主动脉瓣置换术后需植入永久起搏器降低远期生存率
回顾性分析2600例连续接受外科主动脉瓣置换术患者,按术后30天内是否植入永久起搏器分层。72例(2.7%)需植入起搏器,此类患者术后并发症更多、资源利用更高,且远期生存率显著更差(风险比1.48,p=0.02)。
要点
- 术后30天内需植入永久起搏器者占2.7%(72/2600)。
- 起搏器组房颤43.1% vs 27.0%、长时间通气16.7% vs 5.7%、肾衰竭12.5% vs 4.6%。
- 起搏器组中位随访7.5年生存率更差,风险比1.48(p=0.02)。
核心结论
- 主动脉瓣置换术后需植入永久起搏器独立降低远期生存率。
- 外科主动脉瓣置换术后起搏器植入率仍很低,但大幅增加资源利用。
- 随着经导管主动脉瓣置换扩展至低危患者,起搏器植入对远期生存的影响值得密切监测。
研究设计与样本
- 回顾性队列研究,利用胸外科医师学会(STS)机构数据库和社会保障死亡记录,回顾过去15年连续2600例接受外科主动脉瓣置换术的患者。
- 按术后30天内是否植入永久起搏器进行分层,采用Kaplan-Meier分析评估远期生存,并用Cox比例风险模型进行风险校正生存分析。
主要发现
- 72例(2.7%)术后需植入永久起搏器。
- 起搏器组术后并发症更多:房颤43.1% vs 27.0%(p=0.003),长时间通气16.7% vs 5.7%(p<0.0001),肾衰竭12.5% vs 4.6%(p=0.002)。
- 起搏器组资源利用更高:重症监护室停留89 vs 44小时(p<0.0001),住院时间9 vs 6天(p<0.0001),通胀调整后住院费用81000 vs 47000美元(p<0.0001)。
- 中位随访7.5年,起搏器组远期生存率显著更差(p=0.02),经STS预测死亡风险校正后风险比1.48(p=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Permanent pacemaker (PPM) implantation has been touted as an inconsequential complication after transcatheter aortic valve replacement. As transcatheter aortic valve replacement moves to lower risk patients, the long-term implications remain poorly understood; therefore, we evaluated the long-term outcomes of pacemaker for surgical aortic valve replacement patients. METHODS: A total of 2,600 consecutive patients undergoing surgical aortic valve replacement over the past 15 years were reviewed using The Society of Thoracic Surgeons (STS) institutional database and Social Security death records. Patients were stratified by placement of a PPM within 30 days of surgery. The impact of PPM placement on long-term survival was assessed by Kaplan-Meier analysis and risk-adjusted survival by Cox proportional hazards modeling. RESULTS: A total of 72 patients (2.7%) required PPM placement postoperatively. Patients requiring PPM had more postoperative complications, including atrial fibrillation (43.1% versus 27.0%, p = 0.003), prolonged ventilation (16.7% versus 5.7%, p < 0.0001), and renal failure (12.5% versus 4.6%, p = 0.002). These led to greater resource utilization including longer intensive care unit stay (89 versus 44 hours, p < 0.0001) and hospital length of stay (9 versus 6 days, p < 0.0001), and higher inflation-adjusted hospital cost ($81,000 versus $47,000, p < 0.0001). Median follow-up was 7.5 years, and patients requiring PPM had significantly worse long-term survival (p = 0.02), even after risk adjustment with STS predicted risk of mortality (hazard ratio 1.48, p = 0.02). CONCLUSIONS: The need for PPM after aortic valve replacement independently reduces long-term survival. The rate of PPM placement after surgical aortic valve replacement remains very low but dramatically increases resource utilization. As transcatheter aortic valve replacement expands to low-risk patients, the impact of PPM placement on long-term survival warrants close monitoring.
引用
- Mehaffey JH, Haywood NS, Hawkins RB, et al. Need for Permanent Pacemaker After Surgical Aortic Valve Replacement Reduces Long-Term Survival. Ann Thorac Surg. 2018. PMID: 29577930. doi:10.1016/j.athoracsur.2018.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。